ArticlePharmaceuticals (Basel, Switzerland)2022

Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation.

Aziz Unnisa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.